Passer au contenu de la page principale

Brian G. Ballios, MD, PhD, FRCSC, DABO

Conférencier invité
Participe à 1 Session

{"twitch"=>"", "youtube"=>"", "linkedin"=>"", "flickr"=>"", "bio"=>"", "reddit"=>"", "facebook"=>"", "website"=>"", "twitterinfo"=>"", "othersocialmedia"=>"", "instagram"=>""}

Sessions auxquelles Brian G. Ballios, MD, PhD, FRCSC, DABO participe

Samedi 11 Juin, 2022

Fuseau horaire: (GMT-04:00) Atlantic Time (Canada)
2:17 PM - 2:24 PM | 7 minutes
Médecine oculaire régénérative

Sessions auxquelles Brian G. Ballios, MD, PhD, FRCSC, DABO assiste

Samedi 11 Juin, 2022

Fuseau horaire: (GMT-04:00) Atlantic Time (Canada)
6:30 AM - 8:00 AM | 1 heure 30 minutes
Symposium élaboré conjointement

Objectifs d’apprentissageÀ la fin de la session, les participants pourront :Repérer des propositions canadiennes novatrices de recherche en rétine et les avantages escomptésDécrire comment l’utilisation des innovations numériques en ophtalmologie peut optimiser les soins aux patientsRôles CanMEDS : Érudit, expert médicale Le présent symposium a été élaboré conjointement avec la SCO et Bayer de man...

10:45 AM - 12:15 PM | 1 heure 30 minutes
Rétine

Learning ObjectivesAt the end of this session, participants will be able to:Assess and manage vitreoretinal lymphomaDescribe the choroidal changes in the treatment of diabetic retinopathyIntegrate new concepts in retinal detachment managementCanMEDS Roles: Medical Expert, Scholar 

10:45 AM - 12:15 PM | 1 heure 30 minutes
Cornée

Learning Objectives:To review treatment strategies for managing intraocular lens complicationsTo review pearls for performing cataract surgery in patients with corneal conditions.To understand healthcare economics associated with ocular surface disease and cataract surgeryCanMEDS Roles: Medical expert; Scholar

1:30 PM - 3:00 PM | 1 heure 30 minutes
Rétine

Learning ObjectivesAt the end of this session, participants will be able to:Manage macular edema secondary to retinal vein occlusionDescribe management of peripapillary choroidal melanomasIntegrate new concepts in retinal detachment managementCanMEDS Roles: Medical Expert, Scholar

1:30 PM - 3:00 PM | 1 heure 30 minutes
Médecine oculaire régénérative

Learning ObjectivesAt the end of this session, participants will be able to:Define the signs and symptoms of Limbal Stem Cell DeficiencyDescribe the treatment modalities currently in use to treat Limbal Stem Cell DeficiencyDescribe how gene-based therapy is used to treat retinal diseaseDescribe how cell-based therapy is used to treat retinal diseaseCanMEDS Roles: Medical Expert, Professional

3:45 PM - 5:15 PM | 1 heure 30 minutes
Rétine

Learning ObjectivesAt the end of this session, participants will be able to:Describe prognostication for uveal melanomaApply real word data to the management of macular degeneration, diabetic macular edemaAssess patient experiences of inherited retinal diseasesCanMEDS Roles: Medical Expert, Scholar

4:02 PM - 4:09 PM | 7 minutes
Rétine

Authors: Varun Chaudhary, Jean-François Korobelnik, Paul Mitchell, Se Woong Kang, Ramin Tadayoni, Helmut Allmeier, JinKyung Lee, Tobias Machewitz, Kristian T. Johnson, Clare Bailey. Author Disclosure Block: V. Chaudhary: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Novartis, Bayer. Any direct financial payments including receipt of honoraria; Description of relationship(s); Spe...

4:37 PM - 4:44 PM | 7 minutes
Rétine

Authors: Imaan Z. Kherani1, Chad Andrews2, Jennifer Pereira3, Larissa Moniz4, Cynthia X. Qian5. 1Temerty Faculty of Medicine, University of Toronto, 2College of Optometrists of Ontario, 3JRL Research & Consulting Inc., 4Fighting Blindness Canada, 5Department of Ophthalmology, Universite de Montreal.Author Disclosure Block: I.Z. Kherani: None. C. Andrews: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Fighting Blin...

4:59 PM - 5:06 PM | 7 minutes
Rétine

Authors: Ellen Tianwei Zhou, Pierre-Olivier Kassis, Cynthia Qian, Patrick Hamel, Sylvain Chemtob, Anne-Monique Nuyt, Thuy Mai Luu.Author Disclosure Block: E.T. Zhou: None. P. Kassis: None. C. Qian: None. P. Hamel: None. S. Chemtob: None. A. Nuyt: None. T. Luu: None.Purpose: Retinopathy of prematurity (ROP) remains the dominant cause of severe visual impairment in childhood in North America and Europe. With the improvement in ne...

Dimanche 12 Juin, 2022

Fuseau horaire: (GMT-04:00) Atlantic Time (Canada)
6:30 AM - 8:00 AM | 1 heure 30 minutes
Symposium élaboré conjointement

LEARNING OBJECTIVESAt the end of this symposium, participants will be able to:Identify the critical unmet needs in neovascular AMD and DME managementDemonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME managementExamine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DMEApply new insights from multi-modal imagin...

Varun Chaudhary

Modérateur.rice

Michael Ip

Invité.e d'honneur

Dr. Wai-Ching Lam

Conférencier.ère
9:25 AM - 9:30 AM | 5 minutes
Notions courantesPrix
9:30 AM - 10:00 AM | 30 minutes
LauréatNotions courantes
10:45 AM - 12:15 PM | 1 heure 30 minutes
Rétine

Learning ObjectivesAt the end of this session, participants will be able to:Utilize OCT Imaging to differentiate various types of Pigmented Epithelial DetachmentsUtilize OCT Imaging of the choroid...